Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy

被引:0
|
作者
Lucie Blais
Odile Sheehy
Jean-Marc Saint-Hilaire
Gilles-Pierre Bernier
Philippe Godfroid
Jacques LeLorier
机构
[1] University of Montreal Hospital,Research Centre
[2] Health Outcomes Research Unit,undefined
[3] R&D,undefined
[4] UCB Pharma,undefined
来源
PharmacoEconomics | 2005年 / 23卷
关键词
Standard Therapy; Levetiracetam; Seizure Frequency; Epilepsy Surgery; Refractory Epilepsy;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives: This study provides the results of a cost-effectiveness analysis of levetiracetam as an adjunctive treatment for refractory epilepsy from the Canadian Ministry of Health perspective. The main objective is to estimate the expected cost-effectiveness ratio expressed as the incremental cost per seizure-free day gained when using levetiracetam. In addition, this study examines the potential savings that might result by reducing the number of surgical evaluations and surgery when using levetiracetam.
引用
收藏
页码:493 / 503
页数:10
相关论文
共 50 条
  • [1] Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy
    Sheehy, O
    St-Hilaire, JM
    Bernier, G
    Godfroid, P
    LeLorier, JJ
    PHARMACOECONOMICS, 2005, 23 (05) : 493 - 503
  • [2] Levetiracetam add-on therapy in 11 patients with refractory epilepsy
    Merella, W
    Melis, L
    Molari, A
    Murgai, PG
    EPILEPSIA, 2003, 44 : 117 - 117
  • [3] LEVETIRACETAM ADD-ON THERAPY IN CHILDREN WITH REFRACTORY EPILEPSY
    Hung, K-L
    Liaw, H-T
    Lim, A-T
    EPILEPSIA, 2011, 52 : 128 - 128
  • [4] Utility of levetiracetam as and add-on therapy Mexican patients with refractory epilepsy
    Edith, Alva-Moncayo
    Claudia, Sainos-Ramirez
    Francisco Javier, Rogel-Ortiz
    Ruben, Garcia-Garcia
    Enrique, Garcia-Cuevas
    Hugo, Ceja
    Amado Francisco, Rodriguez
    REVISTA MEXICANA DE NEUROCIENCIA, 2011, 12 (03): : 128 - 133
  • [5] Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy
    Tanaka, Shigeya
    Tanaka, Tatsuya
    EPILEPTIC DISORDERS, 2013, 15 (02) : 132 - 141
  • [6] Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy (vol 23, pg 493, 2005)
    Blais, L
    Sheehy, O
    Saint-Hilaire, JM
    Bernier, GP
    Godfroid, P
    Lelorier, J
    PHARMACOECONOMICS, 2005, 23 (09) : 944 - 944
  • [7] EFFECTIVENESS OF LEVETIRACETAM AS ADD-ON THERAPY IN PATIENTS WITH PARTIAL REFRACTORY EPILEPSY
    Kuzmanovski, I.
    Cvetkovska, E.
    Cvetkovska, D. Petrovska
    EPILEPSIA, 2009, 50 : 203 - 203
  • [8] Levetiracetam add-on therapy in our patients with refractory partial epilepsy
    Nezadal, T
    Hovorka, J
    Nemcova, I
    Herman, E
    Bajacek, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S136 - S136
  • [9] Effectiveness of levetiracetam as add-on therapy in patients with partial refractory epilepsy
    Kuzmanovski, I.
    Cvetkovska, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 311 - 311
  • [10] Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
    Suh, Guk-Hee
    Lee, Sang Keol
    PSYCHIATRY INVESTIGATION, 2009, 6 (03) : 185 - 193